[HTML][HTML] Prediction of relapse after antitumor necrosis factor cessation in Crohn's disease: individual participant data meta-analysis of 1317 patients from 14 studies

…, S Bots, R Downey, M Lukas, WC Lin, A Amiot… - Clinical …, 2022 - Elsevier
… of treatment effect after re-introduction. Pooled IPD-MA data analysis on the effect of re-treatment
was … tool to cease anti-TNF in CD has been developed based on multiple cohorts. The …

Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled …

…, J Dale, CM Messow, A McConnachie, A Walker… - The Lancet, 2016 - thelancet.com
… We found several randomised placebo-controlled trials that … given rituximab 1 g by intravenous
infusion on days 1 and 15. … If the true treatment effect difference is zero, and assuming an …

Therapeutic efficacy of fresh, allogeneic mesenchymal stem cells for severe refractory feline chronic gingivostomatitis

B Arzi, KC Clark, A Sundaram, M Spriet… - Stem cells …, 2017 - academic.oup.com
… and tumor necrosis factor alpha concentration) prior to ASC … In this study, we demonstrated
that the IV infusion of a relatively … there are multiple mechanisms of action for ASC therapy in …

[HTML][HTML] Efficacy of intravenous immunoglobulin in neurological diseases

JD Lünemann, I Quast, MC Dalakas - Neurotherapeutics, 2016 - Elsevier
… that infusion of Fc fragments alone is an efficient treatment of … agencies many times do not
approve IVIG therapy, even for … IVIG treatment, interferon-γ and tumor necrosis factor mRNA …

A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis

DH Yoo, CH Suh, SC Shim, S Jeka… - Annals of the …, 2017 - ard.bmj.com
… or intolerance to antitumour necrosis factor (TNF) agents. … Most infusion-related reactions
were grade 1 or 2 in severity; … the same magnitude) were noted in both treatment groups. …

Comparison of therapeutic effects of different mesenchymal stem cells on rheumatoid arthritis in mice

Q Zhang, Q Li, J Zhu, H Guo, Q Zhai, B Li, Y Jin, X He… - PeerJ, 2019 - peerj.com
… Characteristic of RA, tumor necrosis factor α (TNF-α) causes … into consideration, tail vein
infusion was used in this study. … publications then we will send you no more than one email …

Therapeutic efficacy of fresh, autologous mesenchymal stem cells for severe refractory gingivostomatitis in cats

B Arzi, E Mills-Ko, FJM Verstraete, A Kol… - Stem cells …, 2016 - academic.oup.com
… IL-6 and tumor necrosis factor-α concentration. No clinical … ASC treatment than at 6 months
after (multiple comparisons 2-… In this study, we demonstrated that iv infusion of a relatively …

Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma

F Tang, Y Lu, Y Ge, J Shang… - Journal of International …, 2020 - journals.sagepub.com
… Levels of interleukin (IL)-2, IL-6, IL-10, tumor necrosis factor-α… −IV had persistent hyperthermia
from 5−14 days after infusion… , we examined the effects of CAR-T cell infusion on body …

Primary non-response to tumor necrosis factor antagonists is associated with inferior response to second-line biologics in patients with inflammatory bowel diseases: a …

S Singh, J George, BS Boland… - Journal of Crohn's …, 2018 - academic.oup.com
… significant acute or delayed infusion reaction. … made several key observations: [a] patients
with prior PNR to anti-TNF agents were less likely to respond to treatment with another non-anti

[HTML][HTML] Tumor necrosis factor inhibitors

V Gerriets, A Goyal, K Khaddour - 2018 - europepmc.org
… The infusion should occur over at least 2 hours and should … failure NYHA Class III or IV
showed poor cardiac outcomes, … can anti-TNF therapy obtain optimal therapeutic results with …